Biosynthetic growth hormone therapy in children with growth hormone deficiency: experience at AIIMS, New Delhi.
Indian J Pediatr
;
1991 Sep-Oct; 58 Suppl 1(): 71-7
Artículo
en Inglés
| IMSEAR
| ID: sea-84746
ABSTRACT
A total of 20 previously untreated children with growth hormone deficiency (GHD) were treated for one year with biosynthetic human growth hormone (hGH). The mean chronologic age was 9.43 +/- 3.52 years with a height age of 5.02 years, and bone age 9.43 +/- 3.52 (TW2-RUS) 6.42 years. The mean pretreatment growth velocity was 2.43 +/- 0.90 cm/year. Of these 14 children had complete GHD (peak GH levels less than 5 ng/ml) and 6 had partial GHD. They were treated with recombinant GH in a dose of 0.5 IU/kg/week divided into 6-7 injections per week subcutaneously at night. The mean growth velocity increased to 8.88 +/- 2.10 cm/yr at the end of 6 months and 8.00 +/- 2.21 cm/yr at 12 months. The actual gain ranged from 6-11 cm in a year. There were no local adverse reactions. One child developed vitiligo of the face and another transient hyperglycemia.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Factores de Tiempo
/
Estatura
/
Proteínas Recombinantes
/
Femenino
/
Humanos
/
Masculino
/
Hormona del Crecimiento
/
Niño
/
Antropometría
/
Academias e Institutos
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Indian J Pediatr
Año:
1991
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS